E1A Oncoprotein Induced Deregulation of Replication Origin Firing
E1A癌蛋白诱导复制起点激发失调
基本信息
- 批准号:8095862
- 负责人:
- 金额:$ 22.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-02-15 至 2013-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdenovirusesBindingBinding SitesCell Cycle ProgressionCellsChromatinComplexDNA DamageDNA Synthesis InductionDNA biosynthesisDNA replication originDown-RegulationE1A-associated p300 proteinEP300 geneFamilyG0 PhaseGene ExpressionGenesGenetic TranscriptionGrowthHDAC3 geneHistone DeacetylaseHuman DevelopmentIn VitroLicensing FactorLightLinkLytic PhaseMacrophage-1 AntigenMalignant NeoplasmsMediatingModelingMolecularN-terminalNeoplastic Cell TransformationOncogene ProteinsOncogenesOpen Reading FramesPaperPathway interactionsPre-Replication ComplexProtein BindingProtein FamilyProteinsRNA SplicingReplication OriginReportingRetinoblastoma ProteinRodentRoleRunningS PhaseS Phase ArrestSubgroupTimeTransactivationTranscription CoactivatorTransforming Growth FactorsViralVirusYY1 Transcription Factorbasec-myc Genescell growthcell transformationgenetic regulatory proteinhistone deacetylase 3metaplastic cell transformationmutantpolypeptideprematurepreventresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant): The focus of this application is to determine the mechanisms by which adenovirus (Ad) transforming E1A protein induces progression to S phase in quiescent cells, in a p300 binding dependent manner. In cooperation with cellular activated ras or virus encoded E1B19K or 55K proteins and by binding to p300/CBP and Rb family proteins, E1A can transform rodent cells. Interactions of E1A with p300/CBP and Rb proteins in quiescent cells result in rapid induction of S phase. While the inactivation of Rb proteins is well known to induce E2F and S phase, the contribution of E1A binding to p300 has not been thoroughly studied. Previously we showed that p300 prevents premature entry of quiescent cells into S phase by negatively regulating c-Myc. p300 cooperates with transcription factor YY1 and histone deacetylase 3 at an upstream YY1 binding site to keep c-Myc in a repressed state and that this contributes to maintaining cells in G0 phase. E1A induces c-Myc by interfering with this mechanism. Recently, we have discovered that a number of additional genes related to DNA synthesis and cell cycle progression are also repressed by p300 in quiescent cells and these genes are induced by E1A in a p300 binding dependent manner. Either downregulation of p300 by shRNAs or expression of wild type E1A but not p300 binding defective E1A mutants leads to the induction of c-Myc that is linked to rapid induction of S phase, activation of DNA damage response and S phase arrest. These cells contain increased cellular DNA replication origin activity. We now propose studies to determine how the origin activity is deregulated by E1A in a p300 binding dependent manner. These studies are expected to shed new light on E1A mediated aberrant S phase progression and its role in viral and cellular transformation.
PUBLIC HEALTH RELEVANCE: Deregulation of cell growth control by a variety of mechanisms is a key step in the development of human cancer. Adenovirus encoded E1A is a time honored model oncoprotein. Understanding its effects on aberrant S phase progression will advance our understanding of how an oncogene by disrupting the growth inhibitory pathways of a cellular protein contributes to neoplastic transformation.
描述(申请人提供):本申请的重点是确定腺病毒(Ad)转化E1a蛋白以p300结合依赖的方式诱导静止细胞进入S期的机制。E1a与细胞激活的ras或编码E1B19K或55K蛋白的病毒协同作用,结合p300/CBP和Rb家族蛋白,可转化啮齿动物细胞。在静止期细胞中,E1a与p300/CBP和Rb蛋白的相互作用导致S期的快速诱导。虽然Rb蛋白的失活会诱导E2F和S期,但E1A结合对p300的作用还没有得到深入的研究。先前我们已经证明,p300通过负调控c-Myc来阻止静止细胞过早进入S时相。P300与转录因子YY1和组蛋白脱乙酰酶3在YY1的上游结合部位协同作用,使c-Myc处于抑制状态,这有助于维持细胞在G0期。E1a通过干扰这一机制诱导c-Myc。最近,我们发现在静止的细胞中,一些与DNA合成和细胞周期进程相关的额外基因也被p300抑制,这些基因是由E1a以p300结合依赖的方式诱导的。无论是shRNA下调p300,还是野生型E1a的表达而不是p300结合缺陷E1a突变体的表达,都会导致c-Myc的诱导,这与快速诱导S期、激活DNA损伤反应和S期停滞有关。这些细胞含有增加的细胞DNA复制起始活性。我们现在建议进行研究,以确定E1A如何以p300结合依赖的方式解除对起始活性的调控。这些研究有望对E1a介导的异常S期进展及其在病毒和细胞转化中的作用提供新的线索。
公共卫生相关性:通过各种机制放松对细胞生长的控制是人类癌症发展的关键一步。腺病毒编码的E1a是一种历史悠久的模式癌蛋白。了解其在异常S期进展中的作用将促进我们对癌基因如何通过破坏细胞蛋白的生长抑制途径而促进肿瘤转化的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BAYAR THIMMAPAYA其他文献
BAYAR THIMMAPAYA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BAYAR THIMMAPAYA', 18)}}的其他基金
Med1 in Liver Metabolism, Regeneration and Cancer
Med1 在肝脏代谢、再生和癌症中的作用
- 批准号:
8694026 - 财政年份:2013
- 资助金额:
$ 22.88万 - 项目类别:
E1A Oncoprotein Induced Deregulation of Replication Origin Firing
E1A癌蛋白诱导复制起点激发失调
- 批准号:
8225211 - 财政年份:2011
- 资助金额:
$ 22.88万 - 项目类别:
FUNCTIONS OF AN EIA-ASSOCIATED CELLULAR PROTEIN
EIA 相关细胞蛋白的功能
- 批准号:
6513078 - 财政年份:1998
- 资助金额:
$ 22.88万 - 项目类别:
FUNCTIONS OF AN EIA-ASSOCIATED CELLULAR PROTEIN
EIA 相关细胞蛋白的功能
- 批准号:
2468737 - 财政年份:1998
- 资助金额:
$ 22.88万 - 项目类别:
FUNCTIONS OF AN EIA-ASSOCIATED CELLULAR PROTEIN
EIA 相关细胞蛋白的功能
- 批准号:
6447218 - 财政年份:1998
- 资助金额:
$ 22.88万 - 项目类别:
FUNCTIONS OF AN EIA-ASSOCIATED CELLULAR PROTEIN
EIA 相关细胞蛋白的功能
- 批准号:
6376427 - 财政年份:1998
- 资助金额:
$ 22.88万 - 项目类别:
Functions of an E1A-Associated Cellular Protein
E1A 相关细胞蛋白的功能
- 批准号:
7362441 - 财政年份:1998
- 资助金额:
$ 22.88万 - 项目类别:
Functions of an E1A-Associated Cellular Protein
E1A 相关细胞蛋白的功能
- 批准号:
7035332 - 财政年份:1998
- 资助金额:
$ 22.88万 - 项目类别:
Functions of an E1A-Associated Cellular Protein
E1A 相关细胞蛋白的功能
- 批准号:
8066180 - 财政年份:1998
- 资助金额:
$ 22.88万 - 项目类别:
FUNCTIONS OF AN EIA-ASSOCIATED CELLULAR PROTEIN
EIA 相关细胞蛋白的功能
- 批准号:
6173282 - 财政年份:1998
- 资助金额:
$ 22.88万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
- 批准号:
24K15172 - 财政年份:2024
- 资助金额:
$ 22.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
- 批准号:
23K04928 - 财政年份:2023
- 资助金额:
$ 22.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
- 批准号:
10744934 - 财政年份:2023
- 资助金额:
$ 22.88万 - 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
- 批准号:
573688-2022 - 财政年份:2022
- 资助金额:
$ 22.88万 - 项目类别:
University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10704557 - 财政年份:2022
- 资助金额:
$ 22.88万 - 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
- 批准号:
10537846 - 财政年份:2022
- 资助金额:
$ 22.88万 - 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
- 批准号:
2753921 - 财政年份:2022
- 资助金额:
$ 22.88万 - 项目类别:
Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
- 批准号:
10328140 - 财政年份:2022
- 资助金额:
$ 22.88万 - 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
- 批准号:
10621368 - 财政年份:2021
- 资助金额:
$ 22.88万 - 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
- 批准号:
2111821 - 财政年份:2021
- 资助金额:
$ 22.88万 - 项目类别:
Standard Grant